Literature DB >> 12065490

Effect of low- and high-virulence Yersinia enterocolitica strains on the inflammatory response of human umbilical vein endothelial cells.

Geertrui Denecker1, Sabine Tötemeyer, Luís J Mota, Paul Troisfontaines, Isabelle Lambermont, Carine Youta, Isabelle Stainier, Martin Ackermann, Guy R Cornelis.   

Abstract

Pathogenic strains of Yersinia spp. inject a set of Yop effector proteins into eukaryotic cells by using a plasmid-encoded type III secretion system. In this study, we analyzed the inflammatory response of human umbilical vein endothelial cells (HUVECs) after infection with different Yersinia enterocolitica strains. We found that both expression of intercellular adhesion molecule 1 and release of the cytokines interleukin-6 (IL-6) and IL-8 by HUVECs are downregulated in a YopP-dependent way, demonstrating that YopP plays a major role in the inflammatory response of these cells. Infection of HUVECs with several low-virulence (biotype 2, 3, and 4) and high-virulence (biotype 1B) Y. enterocolitica strains showed that biotype 1B isolates are more efficient in inhibiting the inflammatory response than low-virulence Y. enterocolitica strains and that this effect depends on the time of contact. We extended the results of Ruckdeschel et al. and found that on the basis of the presence or absence of arginine-143 of YopP (K. Ruckdeschel, K. Richter, O. Mannel, and J. Heesemann, Infect. Immun. 69:7652-7662, 2001) all the Y. enterocolitica strains used fell into two groups, which correlate with the low- and high-virulence phenotypes. In addition, we found that high-virulence strains inject more YopP into the cytosol of eukaryotic target cells than do low-virulence strains.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065490      PMCID: PMC128109          DOI: 10.1128/IAI.70.7.3510-3520.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector.

Authors:  K Orth; L E Palmer; Z Q Bao; S Stewart; A E Rudolph; J B Bliska; J E Dixon
Journal:  Science       Date:  1999-09-17       Impact factor: 47.728

2.  Suppression of TNF by V antigen of Yersinia spp. involves activated T cells.

Authors:  A Schmidt; M Röllinghoff; H U Beuscher
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

3.  A chromosomally encoded type III secretion pathway in Yersinia enterocolitica is important in virulence.

Authors:  J C Haller; S Carlson; K J Pederson; D E Pierson
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

4.  Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease.

Authors:  K Orth; Z Xu; M B Mudgett; Z Q Bao; L E Palmer; J B Bliska; W F Mangel; B Staskawicz; J E Dixon
Journal:  Science       Date:  2000-11-24       Impact factor: 47.728

Review 5.  Type III secretion: a bacterial device for close combat with cells of their eukaryotic host.

Authors:  G R Cornelis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

6.  Identification of Yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis.

Authors:  A J Darwin; V L Miller
Journal:  Mol Microbiol       Date:  1999-04       Impact factor: 3.501

7.  The high-pathogenicity island of Yersinia enterocolitica Ye8081 undergoes low-frequency deletion but not precise excision, suggesting recent stabilization in the genome.

Authors:  S Bach; C Buchrieser; M Prentice; A Guiyoule; T Msadek; E Carniel
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Common and specific characteristics of the high-pathogenicity island of Yersinia enterocolitica.

Authors:  A Rakin; C Noelting; S Schubert; J Heesemann
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

9.  Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types: development of a delivery system for heterologous proteins.

Authors:  A P Boyd; N Grosdent; S Tötemeyer; C Geuijen; S Bleves; M Iriarte; I Lambermont; J N Octave; G R Cornelis
Journal:  Eur J Cell Biol       Date:  2000-10       Impact factor: 4.492

10.  Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus.

Authors:  E Skrzypek; C Cowan; S C Straley
Journal:  Mol Microbiol       Date:  1998-12       Impact factor: 3.501

View more
  22 in total

Review 1.  Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen).

Authors:  Robert R Brubaker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 2.  Interaction between Yersinia pestis and the host immune system.

Authors:  Bei Li; Ruifu Yang
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

Review 3.  Yersinia type III effectors perturb host innate immune responses.

Authors:  Khavong Pha; Lorena Navarro
Journal:  World J Biol Chem       Date:  2016-02-26

4.  Inhibition of interleukin-8 production in human endothelial cells by Staphylococcus aureus supernatant.

Authors:  A Tajima; K Seki; H Shinji; S Masuda
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

5.  YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.

Authors:  Yue Zhang; James B Bliska
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

Review 6.  Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

Authors:  Benjamin Grabowski; M Alexander Schmidt; Christian Rüter
Journal:  Virulence       Date:  2017-03-15       Impact factor: 5.882

7.  Trimeric autotransporter adhesin-dependent adherence of Bartonella henselae, Bartonella quintana, and Yersinia enterocolitica to matrix components and endothelial cells under static and dynamic flow conditions.

Authors:  Niklas F Müller; Patrick O Kaiser; Dirk Linke; Heinz Schwarz; Tanja Riess; Andrea Schäfer; Johannes A Eble; Volkhard A J Kempf
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

8.  Destabilization of YopE by the ubiquitin-proteasome pathway fine-tunes Yop delivery into host cells and facilitates systemic spread of Yersinia enterocolitica in host lymphoid tissue.

Authors:  Kristin Gaus; Moritz Hentschke; Nicole Czymmeck; Lena Novikova; Konrad Trülzsch; Peter Valentin-Weigand; Martin Aepfelbacher; Klaus Ruckdeschel
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

9.  Differential expression of a virulence factor in pathogenic and non-pathogenic mycobacteria.

Authors:  Edith N G Houben; Anne Walburger; Giorgio Ferrari; Liem Nguyen; Charles J Thompson; Christian Miess; Guido Vogel; Bernd Mueller; Jean Pieters
Journal:  Mol Microbiol       Date:  2009-02-02       Impact factor: 3.501

10.  Role of the Yersinia YopJ protein in suppressing interleukin-8 secretion by human polymorphonuclear leukocytes.

Authors:  Justin L Spinner; Aaron M Hasenkrug; Jeffrey G Shannon; Scott D Kobayashi; B Joseph Hinnebusch
Journal:  Microbes Infect       Date:  2015-09-08       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.